SCHEMBL1463479

SCHEMBL1463479

Nc1ccc(Cl)cc1-c1nnn[nH]1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 8/20 0.57
TSHR P16473 3/20 0.41
CYP3A4 P08684 3/20 0.41
ALDH1A1 P00352 3/20 0.41
ALOX15 P16050 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
DYRK3 O43781 1/20 0.36
CCNA2 P20248 1/20 0.36
CDK2 P24941 1/20 0.36
CDK5 Q00535 1/20 0.36
DYRK1A Q13627 1/20 0.36
CDK5R1 Q15078 1/20 0.36
DYRK2 Q92630 1/20 0.36
DYRK1B Q9Y463 1/20 0.36
TP53 P04637 1/20 0.35
HTR2B P41595 2/20 0.35
PDE4D Q08499 1/20 0.35
PIM1 P11309 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3273740 0.87 IDO1 (0.44) IDO1TSHRCYP3A4ALDH1A1MAPK1
SCHEMBL1308358 0.86 IDO1 (0.41) IDO1TSHRCYP3A4ALDH1A1ALOX15
SCHEMBL5815364 0.82 ALDH1A1 (0.49) IDO1ALDH1A1SMN1; SMN2TP53HTR2B
SCHEMBL5676619 0.81 LMNA (0.40) IDO1ALDH1A1CDK2PIM1RXFP1
SCHEMBL2838019 0.79 IDO1 (0.57) IDO1TSHRALDH1A1MAPK1HSD17B10
SCHEMBL30192181 0.79 IDO1 (0.57) IDO1TSHRALDH1A1MAPK1HSD17B10
SCHEMBL3277817 0.79 IDO1 (0.35) IDO1
SCHEMBL3327873 0.79 GAA (0.34) IDO1MAPK1
SCHEMBL705941 0.79 HSD11B1 (0.44) TSHRALDH1A1SMN1; SMN2TP53HPGD
Hydrochloric Acid SCHEMBL7570994 0.78 IDO1 (0.55) IDO1TSHRALDH1A1MAPK1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017192304-A1 ARYLCARBOXAMIDES AND USES THEREOF INCEPTION 1, INC. (US) 2017-11-09 WO disclosed
US-20110071164-A1 ERG CHANNEL OPENERS FOR THE TREATMENT OF CARDIAC ARRHYTHMIAS OLESEN SOEREN PETER 2011-03-24 US disclosed
US-7851492-B2 ERG channel openers for the treatment of cardiac arrhythmias NEUROSEARCH A/S (DK) 2010-12-14 US disclosed
EP-1663192-B1 hERG1 CHANNEL OPENERS FOR THE TREATMENT OF CARDIAC ARRHYTHMIAS NEUROSEARCH AS (DK) 2008-12-03 EP disclosed
US-20060281794-A1 Erg channel openers for the treatment of cardiac arrhythmias NEUROSEARCH A/S (DK) 2006-12-14 US disclosed
CN-1845726-A Erg channel openers for the treatment of cardiac arrhythmias POSEIDON PHARMACEUTICALS AS (DK) 2006-10-11 CN disclosed
EP-1663192-A1 ERG CHANNEL OPENERS FOR THE TREATMENT OF CARDIAC ARRHYTHMIAS Poseidon Pharmaceuticals A/S (DK) 2006-06-07 EP disclosed
US-6911416-B2 Substituted N-benzoyl-n′(tetrazolylphenyl)-ureas and their use as pest control agents BAYER AKTIENGESELLSCHAFT (DE) 2005-06-28 US disclosed
WO-2005023238-A1 ERG CHANNEL OPENERS FOR THE TREATMENT OF HYPEREXCITABILITY-RELATED NEURONAL DISEASES POSEIDON PHARMACEUTICALS A/S (DK) 2005-03-17 WO disclosed
WO-2005023237-A1 ERG CHANNEL OPENERS FOR THE TREATMENT OF CARDIAC ARRHYTHMIAS POSEIDON PHARMACEUTICALS A/S (DK) 2005-03-17 WO disclosed
US-20040192747-A1 Substituted N-benzoyl-N'-(tetrazolylphenyl)-ureas and their use as pest control agents MAURER FRITZ (DE) 2004-09-30 US disclosed
US-20030187043-A1 SUBSTITUTED N-BENZOYL-N'(TETRAZOLYLPHENYL)-UREAS AND THEIR USE AS PEST CONTROL AGENTS BAYER AKTIENGESELLSCHAFT (DE) 2003-10-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060281794-A1 Erg channel openers for the treatment of cardiac arrhythmias KCNJ2, KCNN3, KCNE1 IDO1 3741/4885TSHR 2533/4885CYP3A4 340/4885
US-20030187043-A1 SUBSTITUTED N-BENZOYL-N'(TETRAZOLYLPHENYL)-UREAS AND THEIR USE AS PEST CONTROL AGENTS UTS2R, DDT, UBXN4 IDO1 1203/4885TSHR 1126/4885CYP3A4 542/4885
US-20110071164-A1 ERG CHANNEL OPENERS FOR THE TREATMENT OF CARDIAC ARRHYTHMIAS KCNJ2, KCNN3, KCNE1 IDO1 3741/4885TSHR 2533/4885CYP3A4 340/4885
US-20040192747-A1 Substituted N-benzoyl-N'-(tetrazolylphenyl)-ureas and their use as pest control agents UTS2R, UBXN1, USP1 IDO1 1042/4885TSHR 1243/4885CYP3A4 519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.